Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Effect of CDT6 on Factors of Angiogenic Balance in Tumour Cell Lines

DIANE R.M.H. BOUÏS, WENDY A. DAM, COBY MEIJER, NANNO H. MULDER and GEKE A.P. HOSPERS
Anticancer Research July 2007, 27 (4B) 2325-2329;
DIANE R.M.H. BOUÏS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
WENDY A. DAM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
COBY MEIJER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NANNO H. MULDER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GEKE A.P. HOSPERS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: g.a.p.hospers{at}int.umcg.nl
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Background: Cornea-derived transcript 6 (CDT6, also known as AngX) is an angiopoietin-related factor resulting in anti-tumour effect in vivo. However, a recent abstract reported that CDT6 can also induce angiogenesis and promotes tumour growth. In our previous work, CDT6 had failed to show pro- or anti-angiogenic effects. It is unknown if CDT6 expression occurs in human cancer. Materials and Methods: An array of human tumour cell lines and tumour tissues was tested for CDT6-gene expression using RT-PCR. To address the controversial role of CDT6 on angiogenesis in different tumour models, the expression levels of four factors of the angiogenic balance (VEGF, endostatin, TIMP-1 and PAI-1) were determined in CDT6-transfected and control cells of the human and murine melanoma cell lines BLM and B16-F10. Endostatin was significantly up-regulated by CDT6 expression in the human model and significantly down-regulated in the mouse model. None of 18 cell lines or 23 tumours expressed CDT6. Conclusion: This contradictory effect on endostatin expression in human and mouse models may be an explanation for the conflicting results for the effect of CDT6 expression on angiogenesis.

  • CDT6
  • endostatin
  • PAI
  • VEGF
  • TIMP
  • angiogenic balance

Footnotes

  • Received February 6, 2007.
  • Revision received April 20, 2007.
  • Accepted April 26, 2007.
  • Copyright© 2007 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 27, Issue 4B
July-August 2007
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Effect of CDT6 on Factors of Angiogenic Balance in Tumour Cell Lines
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
5 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Effect of CDT6 on Factors of Angiogenic Balance in Tumour Cell Lines
DIANE R.M.H. BOUÏS, WENDY A. DAM, COBY MEIJER, NANNO H. MULDER, GEKE A.P. HOSPERS
Anticancer Research Jul 2007, 27 (4B) 2325-2329;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Effect of CDT6 on Factors of Angiogenic Balance in Tumour Cell Lines
DIANE R.M.H. BOUÏS, WENDY A. DAM, COBY MEIJER, NANNO H. MULDER, GEKE A.P. HOSPERS
Anticancer Research Jul 2007, 27 (4B) 2325-2329;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Tenofovir Alafenamide Promotes Differentiation and Induces Apoptosis of AML Cells by Inhibiting Telomerase Reverse Transcriptase
  • VEGF and Hypoxia Independently Induce MDR1 Expression to Promote Endothelial Cell Angiogenesis
  • BIT1 as an Effector of EGFR-TKI-induced Apoptosis via TLE1 Inhibition in Lung Adenocarcinoma Cells
Show more Experimental Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire